Agfa to acquire European maker of contrast media

Article

Agfa HealthCare has signed an agreement with Curagita Holding AG to acquire all the shares of its subsidiary Insight Agents GmbH, a German-based developer and producer of generic contrast media.

Agfa HealthCare has signed an agreement with Curagita Holding AG to acquire all the shares of its subsidiary Insight Agents GmbH, a German-based developer and producer of generic contrast media. Agfa expects to pay about 10 million Euros for the contrast media firm in a deal that the Belgian company is framing as an important strategic step towards future growth opportunities. Insight Agents makes generic contrast media, including the MR contrast agent Magnegita (gadopentetate dimeglumine), a generic form of Magnevist, and Iopamigita (Iopamidol), a generic form of Isovue. Insight’s contrast media are logical additions to Agfa’s portfolio of film, chemicals, and printers, according to Christian Reinaudo, president of Agfa HealthCare. They will be distributed through the company’s extensive logistics and distribution network, he said.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
Diagnostic Imaging’s Weekly Scan: September 28 — October 4
Diagnostic Imaging's Weekly Scan: September 21 — September 27
CT Radiation Exposure and Hematologic Cancers in Children: An Interview with Rebecca Smith-Bindman, MD
© 2025 MJH Life Sciences

All rights reserved.